Oramed Pharmaceuticals Inc. (ORMP)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Document and Entity Information | — |
|
| Audit Information | — |
|
| Statements | ||
| Interim Condensed Consolidated Balance Sheets (unaudited) | — |
|
| Consolidated Balance Sheets | — |
|
| Interim Condensed Consolidated Balance Sheets (unaudited) (P) | — |
|
| Consolidated Balance Sheets (P) | — |
|
| Interim Condensed Consolidated Statements of Comprehensive Income (loss) (unaudited) | — |
|
| Interim Condensed Consolidated Statements of Comprehensive Income (unaudited) | — |
|
| Interim Condensed Consolidated Statements of Comprehensive Loss (unaudited) | — |
|
| Consolidated Statements of Comprehensive Income (loss) | — |
|
| Consolidated Statements of Income (loss) | — |
|
| Interim Condensed Consolidated Statements of Changes In Stockholders Equity (unaudited) | — |
|
| Interim Condensed Consolidated Statements of Comprehensive Loss (unaudited) (P) | — |
|
| Consolidated Statements of Changes In Equity | — |
|
| Interim Condensed Consolidated Statements of Cash Flows (unaudited) | — |
|
| Consolidated Statements of Changes In Equity (P) | — |
|
| Consolidated Statements of Cash Flows | — |
|
| Notes | ||
| Accounts Payable and Accrued Expenses | ||
| Advance Payments For Real Estate | — |
|
| Commitments | ||
| Convertible Secured Promissory Note | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Equity Method Investee | ||
| Financial Income (loss), Net | ||
| Financial Income and Expenses | — |
|
| Financial Income, Net | — |
|
| Financing | — |
|
| General | — |
|
| Income (loss) Per Share of Common Stock | ||
| Insider Trading Arrangements | ||
| Investment In Associate At Fair Value | ||
| Investment In Lifeward | — |
|
| Investment In Real Estate | ||
| Investments, At Fair Value | ||
| Leases | — |
|
| Loan Agreement Measured In Fair Value | ||
| Loan To An Equity Method Investee | — |
|
| Marketable Securities | ||
| Non-marketable Equity Securities | — |
|
| Other Non-marketable Equity Securities | ||
| Pay Vs Performance Disclosure | ||
| Related Party Transactions | ||
| Segment Reporting | ||
| Short-term Borrowings | ||
| Short-term Deposits | — |
|
| Significant Accounting Policies | ||
| Stock-based Compensation | — |
|
| Stockholders' Equity | ||
| Subsequent Events | ||
| Taxes On Income | ||